J. Fernández-Calvo

发表

The value of fluorescence in situ hybridization for the detection of 11q in multiple myeloma.

J. Hernández, N. Gutiérrez, J. S. San Miguel, 2004, Haematologica.

Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics.

A. Órfão, M. Sanz, J. Pérez-Simón, 1999, Blood.

Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes.

J. Miguel, A. Órfão, J. S. San Miguel, 1998, Blood.

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.

J. S. San Miguel, J. Ribera, J. Bladé, 2005, Blood.

FLT3-activating mutations are associated with poor prognostic features in AML at diagnosis but they are not an independent prognostic factor.

Marcos González, J. Miguel, R. García-Sanz, 2004, The hematology journal : the official journal of the European Haematology Association.

Pamidronate induces bone formation in patients with smouldering or indolent myeloma, with no significant anti‐tumour effect

Marcos González, A. Órfão, J. S. San Miguel, 2002, British journal of haematology.

Proliferative activity of plasma cells is the most relevant prognostic factor in elderly multiple myeloma patients

J. Miguel, A. Órfão, J. S. San Miguel, 2004, International journal of cancer.

Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma: monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells.

J. García, J. S. San Miguel, N. Gutiérrez, 2000, Haematologica.

Molecular characterization of acute myeloblastic leukemia according to the new WHO classification: a different distribution in Central-West Spain.

A. Órfão, J. S. San Miguel, M. González, 2001, Haematologica.

Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival

Marcos González, A. Órfão, E. Ocio, 2002, British journal of haematology.

lymphoproliferative disorders with more than one B-cell clone Incidence and clinicobiologic characteristics of leukemic B-cell chronic

Marcos González, J. Miguel, Jesús M. Hernández, 2011 .

Immunophenotypic evaluation of the plasma cell compartment in multiple myeloma: a tool for comparing the efficacy of different treatment strategies and predicting outcome.

A. Órfão, J. S. San Miguel, J. Bladé, 2002, Blood.

and Cytogenetic Characteristics Primary Plasma Cell Leukemia: Clinical, Immunophenotypic, DNA Ploidy,

A. Órfão, M. González, J. Bladé, 2013 .

Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma

A. Órfão, J. S. San Miguel, N. Gutiérrez, 2008, British journal of haematology.

Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.

A. Órfão, J. S. San Miguel, M. Sánchez, 2003, Cancer.

Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients

Marcos González, J. Miguel, A. Órfão, 1997 .

Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.

A. Órfão, J. S. San Miguel, M. González, 1997, Blood.

Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.

M. Tormo, J. Hernández-Rivas, A. Oriol, 2002, Haematologica.

p16/INK4a gene inactivation by hypermethylation is associated with aggressive variants of monoclonal gammopathies.

J. S. San Miguel, R. López-Pérez, J. Hernández, 2001, The hematology journal : the official journal of the European Haematology Association.

Incidence and clinicobiologic characteristics of leukemic B-cell chronic lymphoproliferative disorders with more than one B-cell clone.

Marcos González, A. Órfão, Jesús M. Hernández, 2003, Blood.

Minimal residual disease in adolescent ( older than 14 years ) and adult acute lymphoblastic leukemias : early immunophenotypic evaluation has high clinical value

Norma Gutiérrez, Paulo Lucio, Alberto Orfao, 2003 .

Post-treatment bone marrow residual disease > 5% by flow cytometry is highly predictive of short progression-free and overall survival in patients with Waldenström's macroglobulinemia.

A. Órfão, N. Puig, B. Paiva, 2011, Clinical lymphoma, myeloma & leukemia.

Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.

J. Esteve, E. Montserrat, J. Garcia-conde, 2001, The hematology journal : the official journal of the European Haematology Association.

Characterization of aberrant phenotypes in acute myeloblastic leukemia

J. Miguel, A. Órfão, M. González, 1995, Annals of Hematology.

Central Nervous System (CNS) Relapse in Adult Patients with Acute Lymphoblastic Leukemia (ALL): Frequency and Prognosis in 467 Patients without Cranial Irradiation for CNS Prophylaxis.

J. Sancho, J. Hernández-Rivas, M. Terol, 2005 .

Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma

J. Miguel, J. S. San Miguel, J. Bladé, 2004, British journal of haematology.